[Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
Creutzig
A
A
Caspary
L
L
Radeke
U
U
Specht
S
S
Ranke
C
C
Alexander
K
K
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage; D005080:Exercise Test; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D007383:Intermittent Claudication / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage*; D011897:Random Allocation; D012263:Ribonucleosides / Q000008:administration & dosage*; D012265:Ribonucleotides / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D004338:Drug Combinations; D011459:Prostaglandins E, Synthetic; D012263:Ribonucleosides; D012265:Ribonucleotides; D014665:Vasodilator Agents; C045199:Laevodosin; D000527:Alprostadil
Intermittierende intraarterielle Infusionsbehandlung der schweren Claudicatio intermittens. Ergebnisse einer prospektiven Doppelblindstudie: Prostaglandin E1 versus energiereiche Phosphate.